Skip to main content
. 2016 Jun 1;7:148. doi: 10.3389/fphar.2016.00148

FIGURE 2.

FIGURE 2

Administration enhanced cell viability in OGD/R injured H9c2 cells. a, significantly different from Control group, P < 0.05. b, significantly different from OGD/R group, P < 0.05. c, significantly different from sham group OGD/R + GPL group, P < 0.05.